 SOUTH SAN FRANCISCO, Calif., Dec. 20, 2022 GLOBE NEWSWIRE -- Day One Biopharmaceuticals Nasdaq: DAWN, a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that Dr. Jeremy Bender, chief executive officer, will present during the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9 at 4:30 p.m. Pacific Time 7:30 p.m. Eastern Time. 